Azzur Group and BioSPEQ Announce Merger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Azzur Group and BioSPEQ Announce Merger


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Azzur Group and BioSPEQ, a California-based consulting firm, have merged to create a union that will provide consulting services and project resources within the QA, laboratory, clinical, information technology, business processes, manufacturing, operations, and R&D settings.

The Azzur-BioSPEQ merger is the latest in a series of new developments for Azzur Group. Earlier this month, the company acquired Azot and formed Azzur Engineering.

Azzur Group’s main office is located in Willow Grove, PA, with additional offices in Frederick, MD, San Antonio, TX, Cambridge, MA, Cary, NC and Palo Alto, CA. BioSPEQ is headquartered in Irvine, CA with additional offices in Lexington, MA and San Diego, CA.

Source: Azzur Group

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here